Antibodies against Imood could be potential treatment for OCD
Scientists at Queen Mary University of London and the University of Roehampton, London, have discovered that patients suffering from obsessive compulsive disorder have increased levels of a protein called Immuno-moodulin (Imood) in their lymphocytes, a type of immune cell.
No hay comentarios:
Publicar un comentario